Rubitection is developing a low cost and reliable solution to a common $11 billion healthcare problem, bedsores, with low cost diagnostic system.
Rubitection Inc. is an early stage biotech start up that is commercializing the Rubitect™ Assessment System (RAS). The RAS’s addresses an $11 billion US healthcare problem by providing caregivers with a low cost, and reliable diagnostic tool for pressure ulcers. The RAS’ low risk FDA pathway allows a quick path to a $5.2 billion US market. Recurring revenues from the RAS’ consumable supports long-term revenues.